Home Pharmerit International

Pharmerit International

acquired
-
Health Economics and Outcomes Research Service Provider

Basic Information

Pharmerit International is a research company that provides health economics and outcomes research services. It primarily serves pharmaceutical companies, biotechnology companies, medical device companies, as well as government and hospital research institutions. Its clients include several internationally renowned multinational pharmaceutical companies such as Pfizer, Merck, and Eli Lilly. Pharmerit International has more than 100 researchers globally, distributed across six countries and regions. Consulting services include but are not limited to: Health Technology Assessment (HTA); pharmacoeconomic models: Cost-Effectiveness Analysis (CEA) and Budget Impact Analysis (BIA); design and analysis of Markov models; providing product pricing and reimbursement analysis reports; designing market access pathways; creating value dossiers for health economics and outcomes research; formulating value strategies (Value Proposition) / value stories (Value Story) for new products in related fields.
Pharmerit International
United States of America
101~500 people
January 01, 2000
--